Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
CD44, MMP-2, and MMP-9 are new potential molecular prognostic markers in renal cell carcinoma (RCC). The aim of the study was to analyze whether the expression of CD44, MMP-2, and MMP-9 in association with the histopathological subtype of RCC affects the survival of patients with renal cancer. The s...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/4/1202 |
_version_ | 1797621897543811072 |
---|---|
author | Magdalena Chrabańska Magdalena Rynkiewicz Paweł Kiczmer Bogna Drozdzowska |
author_facet | Magdalena Chrabańska Magdalena Rynkiewicz Paweł Kiczmer Bogna Drozdzowska |
author_sort | Magdalena Chrabańska |
collection | DOAJ |
description | CD44, MMP-2, and MMP-9 are new potential molecular prognostic markers in renal cell carcinoma (RCC). The aim of the study was to analyze whether the expression of CD44, MMP-2, and MMP-9 in association with the histopathological subtype of RCC affects the survival of patients with renal cancer. The study population included 243 clear cell RCC (ccRCC) and 59 non-ccRCC cases. A total of 302 tumors were examined for CD44, MMP2, and MMP9 expression by immunohistochemistry. The expression levels of the proteins were scored by semi-quantitative methods, and the correlation with overall patient survival was verified. We found no significant differences in CD44 expression levels between cc-RCC and non-ccRCC cases; however, significant differences existed in the degree of MMP-2 and MMP-9 expression between cc-RCC and non-ccRCC cases. There was significantly higher MMP expression in non-ccRCC than in ccRCC cases. Univariate Cox regression analysis showed that increased CD44 expression and histopathological subtype of ccRCC were predictors of shorter overall survival. Moreover, MMP-2 overexpression slightly reduced the risk of patient death, while MMP-9 expression did not show an association with patients’ survival. However, on multivariate analysis, only the histopathological subtypes of ccRCC and CD44 expression were independent risk factors for patient death. |
first_indexed | 2024-03-11T09:02:30Z |
format | Article |
id | doaj.art-ed90ee308f7441b0a567f7ad2b396206 |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-11T09:02:30Z |
publishDate | 2023-02-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-ed90ee308f7441b0a567f7ad2b3962062023-11-16T19:37:45ZengMDPI AGCancers2072-66942023-02-01154120210.3390/cancers15041202Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?Magdalena Chrabańska0Magdalena Rynkiewicz1Paweł Kiczmer2Bogna Drozdzowska3Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandDepartment and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandDepartment and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandDepartment and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandCD44, MMP-2, and MMP-9 are new potential molecular prognostic markers in renal cell carcinoma (RCC). The aim of the study was to analyze whether the expression of CD44, MMP-2, and MMP-9 in association with the histopathological subtype of RCC affects the survival of patients with renal cancer. The study population included 243 clear cell RCC (ccRCC) and 59 non-ccRCC cases. A total of 302 tumors were examined for CD44, MMP2, and MMP9 expression by immunohistochemistry. The expression levels of the proteins were scored by semi-quantitative methods, and the correlation with overall patient survival was verified. We found no significant differences in CD44 expression levels between cc-RCC and non-ccRCC cases; however, significant differences existed in the degree of MMP-2 and MMP-9 expression between cc-RCC and non-ccRCC cases. There was significantly higher MMP expression in non-ccRCC than in ccRCC cases. Univariate Cox regression analysis showed that increased CD44 expression and histopathological subtype of ccRCC were predictors of shorter overall survival. Moreover, MMP-2 overexpression slightly reduced the risk of patient death, while MMP-9 expression did not show an association with patients’ survival. However, on multivariate analysis, only the histopathological subtypes of ccRCC and CD44 expression were independent risk factors for patient death.https://www.mdpi.com/2072-6694/15/4/1202CD-44MMP-2MMP-9renal cell carcinomaimmunohistochemistry |
spellingShingle | Magdalena Chrabańska Magdalena Rynkiewicz Paweł Kiczmer Bogna Drozdzowska Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer? Cancers CD-44 MMP-2 MMP-9 renal cell carcinoma immunohistochemistry |
title | Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer? |
title_full | Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer? |
title_fullStr | Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer? |
title_full_unstemmed | Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer? |
title_short | Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer? |
title_sort | does the immunohistochemical expression of cd44 mmp 2 and mmp 9 in association with the histopathological subtype of renal cell carcinoma affect the survival of patients with renal cancer |
topic | CD-44 MMP-2 MMP-9 renal cell carcinoma immunohistochemistry |
url | https://www.mdpi.com/2072-6694/15/4/1202 |
work_keys_str_mv | AT magdalenachrabanska doestheimmunohistochemicalexpressionofcd44mmp2andmmp9inassociationwiththehistopathologicalsubtypeofrenalcellcarcinomaaffectthesurvivalofpatientswithrenalcancer AT magdalenarynkiewicz doestheimmunohistochemicalexpressionofcd44mmp2andmmp9inassociationwiththehistopathologicalsubtypeofrenalcellcarcinomaaffectthesurvivalofpatientswithrenalcancer AT pawełkiczmer doestheimmunohistochemicalexpressionofcd44mmp2andmmp9inassociationwiththehistopathologicalsubtypeofrenalcellcarcinomaaffectthesurvivalofpatientswithrenalcancer AT bognadrozdzowska doestheimmunohistochemicalexpressionofcd44mmp2andmmp9inassociationwiththehistopathologicalsubtypeofrenalcellcarcinomaaffectthesurvivalofpatientswithrenalcancer |